Principal Platform Business System Owner
AbbVie
Summary
The Principal Platform Business System Owner is an established expert in CMC development who applies deep scientific and process knowledge to improve how Development Sciences captures, manages, integrates, and retrieves key scientific data. Working knowledge of enterprise data systems, including Empower Chromatography Data System, Spectrus Enterprise solutions, and electronic laboratory notebook platforms, supports this expertise and enables the role to partner effectively with Information Research, data-system vendors, and contract staff or consultants on workflow templates, integrations, and other platform functionality.
Job description
The role serves as the voice of scientists and Development Sciences system users, translating CMC development needs into the system capabilities and enhancements required to enable emerging data and digital capabilities. In alignment with the OneCMC Data Strategy, the role identifies opportunities to combine and standardize efforts, deploy and expand visualization tooling, make greater use of enterprise infrastructure, and support ELN platform modernization. It also enables automation and AI-driven capabilities by ensuring scientific data is structured, connected, and reusable, and it guides user training and change management for new implementations and upgrades.
- Define and deliver the data-systems strategy for core platforms in scope, aligned with Development Sciences goals, the OneCMC Data Strategy, and the enterprise data and systems architecture.
- Partner with Development Sciences and CMC experts to translate scientific needs into standardized workflows, shared data models, and interoperable platform capabilities.
- Lead user requirements engineering and advise on platform fit ("as-is" vs. "enhanced") and "buy vs. build" decisions.
- Manage vendor relationships with BTS/Information Research IT System Owners, and own functional lifecycle management: updates, upgrades, enhancements, adoption, and rationalization.
- Drive Agile delivery, putting prototype solutions in scientists' hands with rapid iteration.
- Implement data contracts and integration patterns with the CMC Data Warehouse (CMCDW) so data meets defined architecture and metadata standards and is reusable, including for automation and AI.
- Ensure the quality and effectiveness of Digital Transformation results through sound design, risk assessment, and back-up strategies.
- Develop platform roadmaps that balance scientific value, user experience, data integrity, interoperability, regulatory requirements, feasibility, and lifecycle cost.
- Serve as a technical expert across core business platforms: advise and mentor colleagues, peers, and senior management to advance knowledge management, adoption, and cross-CMC standardization.
- Present data-systems concepts and results to scientific and non-scientific leaders and stakeholders.
Requirements
- Bachelor's Degree or equivalent education and typically 16 years of experience
- Master's Degree or equivalent education and typically 14 years of experience
- PhD and typically 8 years of experience
- Background and experience in core Development Sciences business platforms including one or more of the following: eLN, EMPOWER Chromatography Data System, CMC LIMS, Spectrus Platform, R-LIMS and/or other relevant laboratory and manufacturing data systems
- Blend of strong scientific experience in the biotech/pharma industry and excellent IT skills
- Proven ability to innovate with a history of new or improved scientific workflows or data systems advancements
- Interacts effectively and influences diverse groups and maintains strong working relationships with internal and external collaborators
Benefits
- Paid time off
- Medical, Dental & Vision Insurance
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.